跳至主要内容
临床试验/NCT03968471
NCT03968471已完成不适用

Chemotherapy-induced Necrosis in Ewing Sarcoma: Which is the Best Scoring Tool

Istituto Ortopedico Rizzoli1 个研究点 分布在 1 个国家目标入组 474 人开始时间: 2019年5月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
474
试验地点
1
主要终点
retrospective analysis of cases of Ewing sarcomas

研究概览

简要总结

This is single institution cases series review of histological and clinical data

详细描述

Investigators will retrieve from the database of the Rizzoli institute all the cases with a histological diagnosis of Ewing sarcoma from 01 Jan 1982 to 31 Dic 2012

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Male and female patients surgically treated at Rizzoli Institute from 01 Jan 1982 to 31 Dic 2012
  • Patients with diagnosis of Ewing sarcoma of bone who have had neo-adjuvant chemotherapy
  • Diagnosis of Ewing sarcoma localized

排除标准

  • Metastatic disease at presentation
  • Soft tissue origin
  • Radiotherapy before surgery

结局指标

主要结局

retrospective analysis of cases of Ewing sarcomas

时间窗: at baseline (Day0)

Investigators will exam the histological response to chemotherapy in localized Ewing sarcoma of bone and correlate it to clinical outcome.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alberto Righi

Principal Investigator

Istituto Ortopedico Rizzoli

研究点 (1)

Loading locations...

相似试验

Chemotherapy-induced Necrosis in Ewing Sarcoma | 临床试验